STAT

As Trump calls on Congress to lower drug prices, some Democrats cheer. Others scoff

To some Democrats, Trump's remarks on drug pricing were an open invitation to collaborate. Others were confused as to what, exactly, the White House wants.
Rep. Lloyd Doggett (D-Texas)

WASHINGTON — President Trump on Tuesday left Congress a two-syllable mandate on the issue of prescription drug pricing: “Do more.” To some Democrats, the words presented an open invitation to collaborate. Others were left confused as to what, exactly, the White House wants.

In interviews following Trump’s second State of the Union address, the divide among Trump’s opposition party was apparent — between

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Sanders’ Pharma Pressure Campaign, AstraZeneca’s New ADC Factory, And More
Sen. Bernie Sanders is testing the limits of the powers of a Senate chairman with little hope of advancing his drug-pricing agenda legislatively.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT1 min read
STAT+: No, Alcohol Isn’t Good For You. Will New Dietary Guidelines Be Shaped More By Health Or Industry Interests?
More and more studies show that alcohol isn't healthy after all. Dietary guidelines are up for revision in 2025, and already, there's debate over research and industry influence.

Related Books & Audiobooks